Article
Successful Fecal Microbiota Transplants in Post-antibiotic Treated Recurrent Clostridioides difficile Patients Induce Acylcarnitine and Sphingolipid Lipidomic Shifts
2025-11-03
Abstract excerpt
<title>Abstract</title> <p> <italic>Clostridioides difficile</italic> infection (CDI) is an urgent public health threat in the United States, resulting on an annual basis in over half a million cases, more than 29,000 deaths, and $4.8 billion in healthcare costs. While fecal microbiota transplants (FMTs) have proven more effective than standard-of-care antibiotics in resolving recurrent CDI (rCDI), their inhere...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 08901f82-8e41-5361-abd4-a3a2a1804f50
- DOI
- 10.21203/rs.3.rs-7888346/v1
